Further, GBM is remarkably dependent on cholesterol for survival, rendering these tumors sensitive to LXR agonist-dependent cell death, based on identifying and targeting tumor co-dependencies shaped both by aberrant EGFR-mTOR signaling and the brain’s unique biochemical environment [87]. Here, MTOR is linked to neoplasm.